(1) Describe the existing head and neck cancer health disparities literature. (2) Contextualize these studies by using the NIMHD research framework (National Institute on Minority Health and Health Disparities). (3) Explore innovative ideas for further study and intervention.
Data Sources
Ovid MEDLINE, Embase, Web of Science, and Google Scholar.
Review Methods
Databases were systematically searched from inception to April 20, 2020. The PRISMA checklist was followed (Preferred Reporting Items for Systematic Reviews and Meta-analyses). Two authors reviewed all articles for inclusion. Extracted data included health disparity population and outcomes, study details, and main findings and recommendations. Articles were also classified per the NIMHD research framework.
Results
There were 148 articles included for final review. The majority (n = 104) focused on health disparities related to at least race/ethnicity. Greater than two-thirds of studies (n = 105) identified health disparities specific to health behaviors or clinical outcomes. Interaction between the individual domain of influence and the health system level of influence was most discussed (n = 99, 66.9%). Less than half of studies (n = 61) offered specific recommendations or interventions.
Conclusions
There has been extensive study of health disparities for head and neck cancer, largely focusing on individual patient factors or health care access and quality. This review identifies gaps in this research, with large numbers of retrospective database studies and little discussion of potential contributors and explanations for these disparities. We recommend shifting research on disparities upstream toward a focus on community and societal factors, rather than individual, and an evaluation of interventions to promote health equity.
Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020. Phase I Report: Recommendations for the Framework and Format of Healthy People 2020. US Department of Health and Human Services; 2008.
3.
DuranDGPerez-StableEJ. Novel approaches to advance minority health and health disparities research. Am J Public Health. 2019;109(suppl 1):S8-S10.
4.
US Department of Health and Human Services. 2018 National Healthcare Quality and Disparities Report. US Department of Health and Human Services; 2019.
SrinivasanSWilliamsSD. Transitioning from health disparities to a health equity research agenda: the time is now. Public Health Rep. 2014;129(suppl 2):71-76.
7.
AlvidrezJCastilleDLaude-SharpMRosarioATaborD. The National Institute on Minority Health and Health Disparities research framework. Am J Public Health. 2019;109(suppl 1):S16-S20.
8.
NaghaviAOEchevarriaMIStromTJ, et al. Treatment delays, race, and outcomes in head and neck cancer. Cancer Epidemiol. 2016;45:18-25.
9.
GraboyesEMEllisMALiH, et al. Racial and ethnic disparities in travel for head and neck cancer treatment and the impact of travel distance on survival. Cancer. 2018;124(15):3181-3191.
10.
NaghaviAOEchevarriaMIGrassGD, et al. Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies. Cancer. 2016;122(22):3529-3537.
11.
PageMJMcKenzieJEBossuytPM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
12.
von ElmEAltmanDGEggerM, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453-1457.
13.
BrownLMCheckDPDevesaSS. Oropharyngeal cancer incidence trends: diminishing racial disparities. Cancer Causes Control. 2011;22(5):753-763.
14.
ColeLPolfusLPetersES. Examining the incidence of human papillomavirus–associated head and neck cancers by race and ethnicity in the US, 1995-2005. PLoS One. 2012;7(3):e32657.
15.
GuoYMcGorraySPRiggsCEJrLoganHL. Racial disparity in oral and pharyngeal cancer in Florida in 1991-2008: mixed trends in stage of diagnosis. Community Dent Oral Epidemiol. 2013;41(2):110-119.
16.
McLeanALeMayWVilaPWegnerMRemingtonP. Disparities in oral and pharyngeal cancer incidence and mortality among Wisconsin residents, 1999-2002. WMJ. 2006;105(6):32-35.
17.
PetersonCEKhoslaSJeffersonGD, et al. Measures of economic advantage associated with HPV-positive head and neck cancers among non-Hispanic Black and White males identified through the National Cancer Database. Cancer Epidemiol. 2017;48:1-7.
18.
WeatherspoonDJChattopadhyayABoroumandSGarciaI. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010. Cancer Epidemiol. 2015;39(4):497-504.
19.
RamerIVarierIZhangD, et al. Racial disparities in incidence of human papillomavirus–associated oropharyngeal cancer in an urban population. Cancer Epidemiol. 2016;44:91-95.
20.
JohnsonSMcDonaldJTCorstenMJ. Socioeconomic factors in head and neck cancer. J Otolaryngol Head Neck Surg. 2008;37(4):597-601.
21.
RereddySKJordanDRMooreCE. Dying to be screened: exploring the unequal burden of head and neck cancer in health provider shortage areas. J Cancer Educ. 2015;30(3):490-496.
22.
Stanford-MooreGBradshawPWeisslerMC, et al. Interaction between known risk factors for head and neck cancer and socioeconomic status: the Carolina Head and Neck Cancer Study. Cancer Causes Control. 2018;29(9):863-873.
23.
Thompson-HarveyAYetukuriMHansenAR, et al. Rising incidence of late-stage head and neck cancer in the United States. Cancer. 2020;126(5):1090-1101.
24.
CassidyRJSwitchenkoJMEl-DeiryMW, et al. Disparities in postoperative therapy for salivary gland adenoid cystic carcinomas. Laryngoscope. 2019;129(2):377-386.
25.
IwataAJWilliamsAMTaylorARChangSS. Socioeconomic disparities and comorbidities, not race, affect salivary gland malignancy survival outcomes. Laryngoscope. 2017;127(11):2545-2550.
26.
OlarteLSMegwaluUC. The impact of demographic and socioeconomic factors on major salivary gland cancer survival. Otolaryngol Head Neck Surg. 2014;150(6):991-998.
27.
StubbsVCRajasekaranKCannadySBNewmanJGIbrahimSABrantJA. Social determinants of health and survivorship in parotid cancer: an analysis of the National Cancer Database. Am J Otolaryngol. 2020;41(1):7.
28.
BunnellAPettitNReddoutN, et al. Analysis of primary risk factors for oral cancer from select US states with increasing rates. Tob Induc Dis. 2010;8(1):5.
29.
GaubatzMEBukatkoARSimpsonMC, et al. Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States. Oral Oncol. 2019;89:95-101.
30.
GoodwinWJThomasGRParkerDF, et al. Unequal burden of head and neck cancer in the United States. Head Neck. 2008;30(3):358-371.
31.
MahalBAInversoGAizerAADonoffRBChuangSK. Impact of African-American race on presentation, treatment, and survival of head and neck cancer. Oral Oncol. 2014;50(12):1177-1181.
32.
Osazuwa-PetersNMassaSTChristopherKMWalkerRJVarvaresMA. Race and sex disparities in long-term survival of oral and oropharyngeal cancer in the United States. J Cancer Res Clin Oncol. 2016;142(2):521-528.
33.
SubramanianSChenA. Treatment patterns and survival among low-income medicaid patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2013;139(5):489-495.
34.
PikeLRGRoyceTJMahalAR, et al. Outcomes of HPV-associated squamous cell carcinoma of the head and neck: impact of race and socioeconomic status. J Natl Compr Cancer Netw. 2020;18(2):177-184.
35.
SittigMPLuuMYoshidaEJ, et al. Impact of insurance on survival in patients <65 with head and neck cancer treated with radiotherapy. Clin Otolaryngol. 2020;45(1):63-72.
36.
FakhryCKrapchoMEiseleDWD’SouzaG. Head and neck squamous cell cancers in the United States are rare and the risk now is higher among white individuals compared with black individuals. Cancer. 2018;124(10):2125-2133.
37.
RoseBSJeongJHNathSKLuSMMellLK. Population-based study of competing mortality in head and neck cancer. J Clin Oncol. 2011;29(26):3503-3509.
38.
ParkAAlabasterAShenHMellLKKatzelJA. Undertreatment of women with locoregionally advanced head and neck cancer. Cancer. 2019;125(17):3033-3039.
39.
ArbesSJSladeGD. Racial differences in stage at diagnosis of screenable oral cancers in North Carolina. J Public Health Dent. 1996;56(6):352-354.
40.
GourinCGPodolskyRH. Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope. 2006;116(7):1093-1106.
41.
LeboNLKhalilDBalramA, et al. Influence of socioeconomic status on stage at presentation of laryngeal cancer in the United States. Otolaryngol Head Neck Surg. 2019;161(5):800-806.
42.
MegwaluUCMaYF. Racial disparities in oropharyngeal cancer stage at diagnosis. Anticancer Res. 2017;37(2):835-839.
43.
MegwaluUCMaYF. Racial disparities in oropharyngeal cancer survival. Oral Oncol. 2017;65:33-37.
44.
NicholsACBhattacharyyaN. Racial differences in stage and survival in head and neck squamous cell carcinoma. Laryngoscope. 2007;117(5):770-775.
45.
ShiboskiCHSchmidtBLJordanRCK. Racial disparity in stage at diagnosis and survival among adults with oral cancer in the US. Community Dent Oral Epidemiol. 2007;35(3):233-240.
46.
ShinJYTruongMT. Racial disparities in laryngeal cancer treatment and outcome: a population-based analysis of 24,069 patients. Laryngoscope. 2015;125(7):1667-1674.
47.
ZandbergDPLiuSGoloubevaO, et al. Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10-year experience at the University of Maryland Greenebaum Cancer Center. Head Neck. 2016;38(4):564-572.
48.
MurdockJMGluckmanJL. African-American and White head and neck carcinoma patients in a university medical center setting—are treatments provided and are outcomes similar or disparate?Cancer. 2001;91(1):279-283.
49.
Osazuwa-PetersNChristopherKMHussainiASBeheraAWalkerRJVarvaresMA. Predictors of stage at presentation and outcomes of head and neck cancers in a university hospital setting. Head Neck. 2016;38(suppl 1):E1826-E1832.
50.
DwojakSMFinkelsteinDMEmerickKSLeeJHPetereitDGDeschlerDG. Poor survival for American Indians with head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2014;151(2):265-271.
51.
DwojakSMSequistTDEmerickKDeschlerDG. Survival differences among American Indians/Alaska Natives with head and neck squamous cell carcinoma. Head Neck. 2013;35(8):1114-1118.
52.
SchrankTPHanYWeissHRestoVA. Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States—possible role for human papillomavirus in survival disparities. Head Neck. 2011;33(1):45-53.
53.
AgarwalPAgrawalRRJonesEADevaiahAK. Social determinants of health and oral cavity cancer treatment and survival: a competing risk analysis. Laryngoscope. 2020;130(9):2160-2165.
54.
AgarwalPJonesEADevaiahAK. Education and insurance status: impact on treatment and survival of sinonasal cancer patients. Laryngoscope. 2020;130(3):649-658.
55.
ChenAYSchragNMHalpernMTWardEM. The impact of health insurance status on stage at diagnosis of oropharyngeal cancer. Cancer. 2007;110(2):395-402.
56.
CrippenMMEliasMLWeisbergerJS, et al. Refusal of cancer-directed surgery in head and neck squamous cell carcinoma patients. Laryngoscope. 2019;129(6):1368-1373.
57.
FullmerTWildeDCShiJW, et al. Demographic and tumor characteristic impact on laryngeal cancer outcomes in a minority underserved patient population. Otolaryngol Head Neck Surg. 2020;162(6):888-896.
58.
InversoGMahalBAAizerAADonoffRBChuangSK. Health insurance affects head and neck cancer treatment patterns and outcomes. J Oral Maxillofac Surg. 2016;74(6):1241-1247.
59.
KwokJLangevinSMArgirisAGrandisJRGoodingWETaioliE. The impact of health insurance status on the survival of patients with head and neck cancer. Cancer. 2010;116(2):476-485.
60.
MehtaVShiZZMillsGMNathanCAOShiRH. Effect of payer status on relative survival of patients with laryngeal cancer. Anticancer Res. 2016;36(1):327-333.
61.
PagedarNADavisABSperrySMCharltonMELynchCF. Population analysis of socioeconomic status and otolaryngologist distribution on head and neck cancer outcomes. Head Neck. 2019;41(4):1046-1052.
62.
RohlfingMLMaysACIsomSWaltonenJD. Insurance status as a predictor of mortality in patients undergoing head and neck cancer surgery. Laryngoscope. 2017;127(12):2784-2789.
63.
ShinJYYoonJKShinAKBlumenfeldPMaiMDiazAZ. Association of insurance and community-level socioeconomic status with treatment and outcome of squamous cell carcinoma of the pharynx. JAMA Otolaryngol Head Neck Surg. 2017;143(9):899-907.
64.
ShinJYYoonJKShinAKDiazAZ. The influence of insurance status on treatment and outcomes in oral cavity cancer: an analysis on 46,373 patients. Int J Oral Maxillofac Surg. 2018;47(10):1250-1257.
65.
StubbsVCRajasekaranKChenJCannadySBBrantJANewmanJG. Impact of payer status on survival in parotid malignancy. Am J Otolaryngol. 2019;40(4):555-559.
66.
SimpsonMCChallapalliSDCassLM, et al. Impact of gender on the association between marital status and head and neck cancer outcomes. Oral Oncol. 2019;89:48-55.
67.
FarquharDRMasoodMMLenzeNR, et al. Travel time to provider is associated with advanced stage at diagnosis among low income head and neck squamous cell carcinoma patients in North Carolina. Oral Oncol. 2019;89:115-120.
68.
RingstromMJChristianJBushMLLevyJEHuangBGalTJ. Travel distance: impact on stage of presentation and treatment choices in head and neck cancer. Am J Otolaryngol. 2018;39(5):575-581.
69.
ZunigaSALangoMN. Effect of rural and urban geography on larynx cancer incidence and survival. Laryngoscope. 2018;128(8):1874-1880.
70.
SineshawHMEllisMAYabroffKR, et al. Association of Medicaid expansion under the Affordable Care Act with stage at diagnosis and time to treatment initiation for patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2020;146(3):247-255.
71.
DuXLLLiuCC. Racial/ethnic disparities in socioeconomic status, diagnosis, treatment and survival among Medicare-insured men and women with head and neck cancer. J Health Care Poor Underserved. 2010;21(3):913-930.
72.
LewisCMAjmaniGSKyrillosA, et al. Racial disparities in the choice of definitive treatment for squamous cell carcinoma of the oral cavity. Head Neck. 2018;40(11):2372-2382.
73.
NoconCCAjmaniGSBhayaniMK. A contemporary analysis of racial disparities in recommended and received treatment for head and neck cancer. Cancer. 2020;126(2):381-389.
74.
WengYKorteJE. Racial disparities in being recommended to surgery for oral and oropharyngeal cancer in the United States. Community Dent Oral Epidemiol. 2012;40(1):80-88.
75.
TomarSLLoreeMLoganH. Racial differences in oral and pharyngeal cancer treatment and survival in Florida. Cancer Causes Control. 2004;15(6):601-609.
76.
GraboyesEMGarrett-MayerESharmaAKLentschEJDayTA. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017;123(14):2651-2660.
77.
GuttmannDMKobieJGroverS, et al. National disparities in treatment package time for resected locally advanced head and neck cancer and impact on overall survival. Head Neck. 2018;40(6):1147-1155.
78.
KompelliACartmellKBSterbaKR, et al. An assessment of racial differences in epidemiological, clinical and psychosocial factors among head and neck cancer patients at the time of surgery. World J Otorhinolarygol Head Neck Surg. 2020:6(1):41-48.
79.
AlbertAGiriSKanakamedalaM, et al. Racial disparities in tumor features and outcomes of patients with squamous cell carcinoma of the tonsil. Laryngoscope. 2019;129(3):643-654.
80.
GuerrieroMKRedmanMWBakerKK, et al. Racial disparity in oncologic and quality-of-life outcomes in patients with locally advanced head and neck squamous cell carcinomas enrolled in a randomized phase 2 trial. Cancer. 2018;124(13):2841-2849.
81.
HayesDNPengGBPennellaE, et al. An exploratory subgroup analysis of race and gender in squamous cancer of the head and neck: inferior outcomes for African American males in the LORHAN database. Oral Oncol. 2014;50(6):605-610.
82.
IsayevaTXuJDaiQ, et al. African Americans with oropharyngeal carcinoma have significantly poorer outcomes despite similar rates of human papillomavirus–mediated carcinogenesis. Hum Path. 2014;45(2):310-319.
83.
SmithSPRussellJLChenN-WKuoY-FRestoVA. Sinonasal carcinoma: racial and ethnic disparities in survival—a review of 4714 patients. Otolaryngol Head Neck Surg. 2015;153(4):551-560.
84.
ChallapalliSDSimpsonMCAdjei BoakyeE, et al. Survival differences in nasopharyngeal carcinoma among racial and ethnic minority groups in the United States: a retrospective cohort study. Clinical Otolaryngol. 2019;44(1):14-20.
85.
ChenLMLiGJReitzelLR, et al. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila). 2009;2(9):782-791.
86.
LiuGFFRanckMCSolankiAA, et al. Racial parities in outcomes after radiotherapy for head and neck cancer. Cancer. 2014;120(2):244-252.
87.
RaginCCLangevinSMMarzoukMGrandisJTaioliE. Determinants of head and neck cancer survival by race. Head Neck. 2011;33(8):1092-1098.
88.
SandulacheVCKubikMWSkinnerHDMalskyJAGelbardAHZevallosJP. Impact of race/ethnicity on laryngeal cancer in patients treated at a Veterans Affairs medical center. Laryngoscope. 2013;123(9):2170-2175.
89.
ZevallosJPSandulacheVCHamblinJ, et al. Impact of race on oropharyngeal squamous cell carcinoma presentation and outcomes among veterans. Head Neck. 2016;38(1):44-50.
90.
SharmaSBekelmanJLinA, et al. Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma. Oral Oncol. 2016;56:17-24.
91.
CannonRBShepherdHMMcCraryH, et al. Association of the Patient Protection and Affordable Care Act with insurance coverage for head and neck cancer in the SEER database. JAMA Otolaryngol Head Neck Surg. 2018;144(11):1052-1057.
92.
ChallapalliSDSimpsonMCBoakyeEAPannuJSCostaDJOsazuwa-PetersN. Head and neck squamous cell carcinoma in adolescents and young adults: survivorship patterns and disparities. J Adolesc Young Adult Oncol. 2018;7(4):472-479.
93.
ChoiSHTerrellJEFowlerKE, et al. Socioeconomic and other demographic disparities predicting survival among head and neck cancer patients. PloS One. 2016;11(3):e0149886.
94.
GaubatzMEBukatkoARSimpsonMC, et al. Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States. Oral Oncol. 2019;89:95-101.
95.
KonskiAAPajakTFMovsasB, et al. Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trials. J Clin Oncol. 2006;24(25):4177-4183.
96.
MegwaluUC. Impact of county-level socioeconomic status on oropharyngeal cancer survival in the United States. Otolaryngol Head Neck Surg. 2017;156(4):665-670.
97.
MolinaMACheungMCPerezEA, et al. African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer. 2008;113(10):2797-2806.
98.
XuCChenYPLiuX, et al. Socioeconomic factors and survival in patients with non-metastatic head and neck squamous cell carcinoma. Cancer Sci. 2017;108(6):1253-1262.
99.
FakhryCWestraWHWangSJ, et al. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer. 2017;123(9):1566-1575.
100.
SabaNFGoodmanMWardK, et al. Gender and ethnic disparities in incidence and survival of squamous cell carcinoma of the oral tongue, base of tongue, and tonsils: a Surveillance, Epidemiology and End Results program-based analysis. Oncology. 2011;81(1):12-20.
101.
SainiATGendenEMMegwaluUC. Sociodemographic disparities in choice of therapy and survival in advanced laryngeal cancer. Am J Otolaryngol. 2016;37(2):65-69.
102.
MassaSTLiebendorferAPZevallosJPMazulAL. Distance traveled to head and neck cancer provider: a measure of socioeconomic status and access. Otolaryngol Head Neck Surg. 2020;162(2):193-203.
103.
ReeveBBCaiJWZhangHT, et al. Health-related quality of life differences between African Americans and non-Hispanic Whites with head and neck cancer. Head Neck. 2013;35(9):1255-1264.
104.
ReeveBBCaiJZhangH, et al. Factors that impact health-related quality of life over time for individuals with head and neck cancer. Laryngoscope. 2016;126(12):2718-2725.
105.
LoehnBPouAMNussDW, et al. Factors affecting access to head and neck cancer care after a natural disaster: a post–Hurricane Katrina survey. Head Neck. 2011;33(1):37-44.
106.
MooreCEWarrenRMaclinSDJr. Head and neck cancer disparity in underserved communities: probable causes and the ethics involved. J Health Care Poor Underserved. 2012;23(4, suppl):88-103.
107.
KingsleyKO’MalleySDitmyerMChinoM. Analysis of oral cancer epidemiology in the US reveals state-specific trends: implications for oral cancer prevention. BMC Public Health. 2008;8:87.
108.
DahlstromKRBellDHanbyD, et al. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior. Oral Oncol. 2015;51(9):832-838.
109.
LenzeNRFarquharDRMazulALMasoodMMZevallosJP. Racial disparities and human papillomavirus status in oropharyngeal cancer: a systematic review and meta-analysis. Head Neck. 2019;41(1):256-261.
110.
SteinELenzeNRYarbroughWGHayesDNMazulAShethS. Systematic review and meta-analysis of racial survival disparities among oropharyngeal cancer cases by HPV status. Head Neck. 2020;42(10):2985-3001.
111.
RussoDPThamTBardashYKrausD. The effect of race in head and neck cancer: a meta-analysis controlling for socioeconomic status. Am J Otolaryngol. 2020;41(6):102624.
112.
RileyWJ. Health disparities: gaps in access, quality and affordability of medical care. Trans Am Clin Climatol Assoc. 2012;123:167-172.
113.
ChauhanAWaltonMManiasE, et al. The safety of health care for ethnic minority patients: a systematic review. Int J Equity Health. 2020;19(1):118.
114.
Cooper-PatrickLGalloJJGonzalesJJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999;282(6):583-589.
115.
SerchenJDohertyRAtiqOHildenD. Racism and health in the United States: a policy statement from the American College of Physicians. Ann Intern Med. 2020;173(7):556-557.
116.
BleichSNFindlingMGCaseyLS, et al. Discrimination in the United States: experiences of Black Americans. Health Serv Res. 2019;54(suppl 2):1399-1408.
117.
GambleVN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87(11):1773-1778.
118.
ChenMMRomanSAYarbroughWGBurtnessBASosaJAJudsonBL. Trends and variations in the use of adjuvant therapy for patients with head and neck cancer. Cancer. 2014;120(21):3353-3360.
119.
LehrmanWGElliottMNGoldsteinEBeckettMKKleinDJGiordanoLA. Characteristics of hospitals demonstrating superior performance in patient experience and clinical process measures of care. Med Care Res Rev. 2010;67(1):38-55.
120.
HanXYabroffKRWardEBrawleyOWJemalA. Comparison of insurance status and diagnosis stage among patients with newly diagnosed cancer before vs after implementation of the Patient Protection and Affordable Care Act. JAMA Oncol. 2018;4(12):1713-1720.
121.
JemalALinCCDavidoffAJHanX. Changes in insurance coverage and stage at diagnosis among nonelderly patients with cancer after the Affordable Care Act. J Clin Oncol. 2017;35(35):3906-3915.
122.
McGheeEHarperHUmeA, et al. Elimination of cancer health disparities through the acceleration of HPV vaccines and vaccinations: a simplified version of the President’s Cancer Panel report on HPV vaccinations. J Vaccines Vaccin. 2017;8(3):361.
123.
BushMLKaufmanMRShacklefordT. Adherence in the cancer care setting: a systematic review of patient navigation to traverse barriers. J Cancer Educ. 2018;33(6):1222-1229.
124.
JamesSA. Epidemiologic research on health disparities: some thoughts on history and current developments. Epidemiol Rev. 2009;31:1-6.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
